FLURAZEPAM TOXICOLOGY CONTROL— 510(k) K831741

Substantially Equivalent

Utak Laboratories, Inc.

FDA 510(k) clearance K831741 for FLURAZEPAM TOXICOLOGY CONTROL, Substantially Equivalent on 1983-07-26. Applicant: Utak Laboratories, Inc..

Clearance details

Applicant
Utak Laboratories, Inc.
Product code
Code DIF
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mchenry, IL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.